» Articles » PMID: 15284856

Hematological Defects in the Oc/oc Mouse, a Model of Infantile Malignant Osteopetrosis

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2004 Jul 31
PMID 15284856
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Infantile malignant osteopetrosis (IMO) is a rare and lethal disease characterized by an absence of bone resorption due to inactive OCLs. Affected patients display an increased bone mass and hematological defects. The osteopetrotic oc/oc mouse displays a bone phenotype similar to the one observed in IMO patients, and the same gene, Tcirg1, is mutated in this model and in the majority of these patients. Therefore, we explored in oc/oc mice the consequences of the perturbed bone microenvironment on hematopoiesis. We show that the myelomonocytic differentiation is increased, leading to an elevated number of OCLs and dendritic cells. B lymphopoiesis is blocked at the pro-B stage in the bone marrow of oc/oc mouse, leading to a low mature B-cell number. T-cell activation is also affected, with a reduction of IFNgamma secretion by splenic CD4(+) T cells. These alterations are associated with a low IL-7 expression in bone marrow. All these data indicate that the lack of bone resorption in oc/oc mice has important consequences in both myelopoiesis and lymphopoiesis, leading to a form of immunodeficiency. The oc/oc mouse is therefore an appropriate model to understand the hematological defects described in IMO patients, and to derive new therapeutic strategies.

Citing Articles

Correction of osteopetrosis in the neonate murine model after lentiviral vector gene therapy and non-genotoxic conditioning.

Penna S, Zecchillo A, Di Verniere M, Fontana E, Iannello V, Palagano E Front Endocrinol (Lausanne). 2024; 15:1450349.

PMID: 39314524 PMC: 11416974. DOI: 10.3389/fendo.2024.1450349.


Molecular Mechanisms of Craniofacial and Dental Abnormalities in Osteopetrosis.

Ma Y, Xu Y, Zhang Y, Duan X Int J Mol Sci. 2023; 24(12).

PMID: 37373559 PMC: 10299715. DOI: 10.3390/ijms241210412.


The road of NSCLC stem cells toward bone metastases.

Bertolini G, Roato I Bone Rep. 2022; 17:101619.

PMID: 36110341 PMC: 9467890. DOI: 10.1016/j.bonr.2022.101619.


The Bone Marrow Microenvironment in B-Cell Development and Malignancy.

Hughes A, Kuek V, Kotecha R, Cheung L Cancers (Basel). 2022; 14(9).

PMID: 35565219 PMC: 9102980. DOI: 10.3390/cancers14092089.


A signaling axis is a critical mediator of regulatory network in T lymphopoiesis.

Mutabaruka M, Pata M, Vacher J iScience. 2022; 25(4):104160.

PMID: 35434560 PMC: 9010627. DOI: 10.1016/j.isci.2022.104160.